Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Active, Not Recruiting

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT06790966

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • University of California, Orange Orange, California, United States
  • Yale University New Haven, Connecticut, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

NCT01898494

Conditions
Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT05287113

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Mayo Clinic Rochester Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Irvine, California, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
View all 91 locations
View Trial Details
Active, Not Recruiting

A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

NCT04670679

Conditions
Advanced or Metastatic Solid Tumors, Carcinoma, Carcinoma, Squamous Cell, +33 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Sarah Cannon Research Institute (Florida Cancer Specialists) Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC

NCT03410615

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • University Hospital of Antwerp Edegem, Belgium
  • University Hospital of Gent Ghent, Belgium
  • University Hospital Leuven Leuven, Belgium
View all 26 locations
View Trial Details
Active, Not Recruiting

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

NCT02503423

Conditions
Carcinoma, Carcinoma, Squamous Cell, Female Urogenital Diseases, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 68 locations
View Trial Details

Related conditions